We need to talk about MOG

Affiliations

¹ From the Nuffield Department of Clinical Neurosciences, University of Oxford, UK. paddy.waters@ndcn.ox.ac.uk.
² From the Nuffield Department of Clinical Neurosciences, University of Oxford, UK.

Editorial

Patrick Waters et al. Neurology. 2020.

. 2020 Jul 14;95(2):55-56.

doi: 10.1212/WNL.0000000000009768. Epub 2020 Jun 17.

¹ From the Nuffield Department of Clinical Neurosciences, University of Oxford, UK. paddy.waters@ndcn.ox.ac.uk.
² From the Nuffield Department of Clinical Neurosciences, University of Oxford, UK.

No abstract available

Comment on

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Chen JJ, et al. Neurology. 2020 Jul 14;95(2):e111-e120. doi: 10.1212/WNL.0000000000009758. Epub 2020 Jun 17. Neurology. 2020. PMID: 32554760 Free PMC article.